https://pipelinereview.com/eleven-biotherapeutics-to-collaborate-with-astrazeneca-and-the-national-cancer-institute-on-development-of-viciniumtm-in-combination-with-durvalumab-for-the-treatment-of-non-muscle-invasive-bladder-ca/